Access to Drugs

23 posts

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313

Asrar Qureshi’s blog delves into the complex journey of health innovations from discovery to patient access, highlighting the significant costs and time involved in drug development. It emphasizes the need for a collaborative approach between pharmaceutical companies and governments to address pricing, making life-saving medications accessible while managing risks and uncertainties effectively.
Share
View Post
  • 6 min

Kiran Mazumdar-Shaw’s Bold Healthcare Mission – Asrar Qureshi’s Blog Post #1203

Asrar Qureshi’s blog post highlights Kiran Mazumdar-Shaw’s transformative journey with Biocon, emphasizing her mission-driven leadership in biotechnology. She advocates for affordable, accessible healthcare and resilient innovation, turning challenges into opportunities. Mazumdar-Shaw’s insights stress the importance of purpose, collaboration, and ecosystem development in creating impactful healthcare solutions for emerging markets.
Share
View Post
  • 5 min

Drugs Shortage and Supply Chain – Asrar Qureshi’s Blog Post #1029

Asrar Qureshi’s blog post #1029 emphasizes the critical role of the supply chain in the pharmaceutical industry, discussing material planning, procurement, inventory management, and warehousing issues in Pakistan. It highlights inefficiencies leading to drug shortages and advocates for qualified professionals, better technology, training, and incremental investment to enhance supply chain performance.
Share